| 臺大學術典藏 |
2021-06-04T08:33:24Z |
An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells
|
Chao M.-W.;Huang H.-L.;Huangfu W.-C.;Hsu K.-C.;Liu Y.-M.;Wu Y.-W.;Lin C.-F.;Chen Y.-L.;Lai M.-J.;Lee H.-Y.;Liou J.P.;Teng C.-M.;Chia-Ron Yang; Chao M.-W.; Huang H.-L.; HuangFu W.-C.; Hsu K.-C.; Liu Y.-M.; Wu Y.-W.; Lin C.-F.; Chen Y.-L.; Lai M.-J.; Lee H.-Y.; Liou J.P.; Teng C.-M.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:24Z |
3-Aroylindoles display antitumor activity in?vitro and in?vivo: Effects of N1-substituents on biological activity
|
Lee H.-Y.;Lee J.-F.;Kumar S.;Wu Y.-W.;Huangfu W.-C.;Lai M.-J.;Li Y.-H.;Huang H.-L.;Kuo F.-C.;Hsiao C.-J.;Cheng C.-C.;Chia-Ron Yang;Liou J.-P.; Lee H.-Y.; Lee J.-F.; Kumar S.; Wu Y.-W.; HuangFu W.-C.; Lai M.-J.; Li Y.-H.; Huang H.-L.; Kuo F.-C.; Hsiao C.-J.; Cheng C.-C.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:24Z |
Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma
|
Chen M.-C.; Huang H.-H.; Lai C.-Y.; Lin Y.-J.; Liou J.-P.; Lai M.-J.; Li Y.-H.; Teng C.-M.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:24Z |
2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase
|
Lee H.-Y.; Chang C.-Y.; Su C.-J.; Huang H.-L.; Mehndiratta S.; Chao Y.-H.; Hsu C.-M.; Kumar S.; Sung T.-Y.; Huang Y.-Z.; Li Y.-H.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:23Z |
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo
|
Lee H.-Y.; Nepali K.; Huang F.-I.; Chang C.-Y.; Lai M.-J.; Li Y.-H.; Huang H.-L.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:23Z |
Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo
|
Huangfu W.-C.; Chao M.-W.; Cheng C.-C.; Wei Y.-C.; Wu Y.-W.; Liou J.-P.; Hsiao G.; Lee Y.-C.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:22Z |
MPT0G413, A novel HDAC6-selective inhibitor, and bortezomib synergistically exert anti-tumor activity in multiple myeloma cells
|
Huang F.-I.;Wu Y.-W.;Sung T.-Y.;Liou J.-P.;Lin M.-H.;Pan S.-L.;Chia-Ron Yang; Huang F.-I.; Wu Y.-W.; Sung T.-Y.; Liou J.-P.; Lin M.-H.; Pan S.-L.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:22Z |
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
|
Tu H.-J.; Lin Y.-J.; Chao M.-W.; Sung T.-Y.; Wu Y.-W.; Chen Y.-Y.; Lin M.-H.; Liou J.-P.; Pan S.-L.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:22Z |
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes
|
Lee H.-Y.; Fan S.-J.; Huang F.-I.; Chao H.-Y.; Hsu K.-C.; Lin T.E.; Yeh T.-K.; Lai M.-J.; Li Y.-H.; Huang H.-L.; CHIA-RON YANG; Liou J.-P. |
| 臺大學術典藏 |
2021-06-04T08:33:22Z |
The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model article
|
Fan S.-J.; Huang F.-I.; Liou J.-P.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:21Z |
Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
|
Hsieh Y.-L.;Tu H.-J.;Pan S.-L.;Liou J.-P.;Chia-Ron Yang; Hsieh Y.-L.; Tu H.-J.; Pan S.-L.; Liou J.-P.; CHIA-RON YANG |
| 臺大學術典藏 |
2021-06-04T08:33:19Z |
A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo
|
Wu Y.-W.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Hsu K.-C.; Liou J.-P.; CHIA-RON YANG; Yen S.-C.; HuangFu W.-C.; Pan S.-L. |
| 臺大學術典藏 |
2021-05-18T01:38:04Z |
HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression
|
Fang Y.-C.;Chan L.;Liou J.-P.;Yong-Kwang Tu;Lai M.-J.;Chen C.-I.;Vidyanti A.N.;Lee H.-Y.;Hu C.-J.; Fang Y.-C.; Chan L.; Liou J.-P.; YONG-KWANG TU; Lai M.-J.; Chen C.-I.; Vidyanti A.N.; Lee H.-Y.; Hu C.-J. |
| 臺大學術典藏 |
2021-05-18T01:38:04Z |
Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment
|
Kaur N.; Fang Y.-C.; Lee H.-Y.; Singh A.; Nepali K.; Lin M.-H.; Yeh T.-K.; Lai M.-J.; Chan L.; YONG-KWANG TU; Banerjee S.; Hu C.-J.; Liou J.-P. |
| 臺大學術典藏 |
2020-07-01T07:18:19Z |
Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2
|
Hou P.;Ching-Ying Kuo;Cheng C.-T.;Liou J.-P.;Ann D.K.;Chen Q.; Hou P.; CHING-YING KUO; Cheng C.-T.; Liou J.-P.; Ann D.K.; Chen Q. |
| 臺大學術典藏 |
2018-09-10T09:41:13Z |
The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells
|
Chen, M.-C.;Chen, C.-H.;Wang, J.-C.;Tsai, A.-C.;Liou, J.-P.;Pan, S.-L.;Teng, C.-M.; CHE-MING TENG |
| 臺大學術典藏 |
2018-09-10T05:45:17Z |
Novel radical synthesis of morphine fragments spiro[benzofuran-3(2H),4'-piperidine] and octahydro-1H-benzofuro[3,2-e]isoquinoline
|
Cheng, C.-Y.;Hsin, L.-W.;Liou, J.-P.; LING-WEI HSIN |
| 國立成功大學 |
2017 |
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
|
Chang, K.-Y.;Hsu, T.-I.;Hsu, C.-C.;Tsai, S.-Y.;Liu, J.-J.;Chou, S.-W.;Liu, M.-S.;Liou, J.-P.;Ko, C.-Y.;Chen, K.-Y.;Hung, J.-J.;Chang, W.-C.;Chuang, Chuang C.-K.;Kao, T.-J.;Chuang, J.-Y. |
| 國立成功大學 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L |
| 朝陽科技大學 |
2014-02 |
An Integrative Process Model of Users’ Health Information Search Behavior and Information Adoption
|
劉熒潔;Liou, J-P |
| 臺北醫學大學 |
2014 |
Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
|
Hsieh, I-N;Liou, J-P;Lee, H-Y;Lai, M-J;Li, Y-H;Yang, C-R |
| 國立臺灣大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L; 鄧哲明 |
| 國立臺灣大學 |
2014 |
Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
|
Hsieh, I-N; Liou, J-P; Lee, H-Y; Lai, M-J; Li, Y-H; Yang, C-R; 楊家榮 |
| 臺北醫學大學 |
2013 |
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
|
Kao, Y. H.;Liou, J. P.;Chung, Chung C. C.;Lien, G. S.;Kuo, C. C.;Chen, S. A.;Chen, Y. J. |
| 臺北醫學大學 |
2013 |
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
|
Kao, Y.H.;Liou, J.P.;Chung, C.C.;Lien, G.S.;Kuo, C.C.;Chen, S.A.;Chen, Y.J. |
